Preventive Cardiovascular Nurses Association

PCNA Login



Forgot Password?

Women's Health in Menopause and Later Years
1 CE Credit
Release Date: January 2005
COURSE OVERVIEW:
The purpose of this presentation is to provide a summary of the physiological changes experienced in the peri-menopausal transition. Pathological changes, including premature and induced menopause will be discussed. Other disease processes that can mimic or occur simultaneously will be presented, including thyroid disease, osteoporosis, cancer, and heart disease. The role of pharmacological and non-pharmacological therapies will be introduced. Lastly, a summary of the controversy over hormone replacement therapy will be addressed and will include current recommendations for therapy.

PRESENTER:
Sue A. Woodson, MSN, CNM
University of Virginia Health System
Department of Obstetrics & Gynecology
Charlottesville, VA

EDUCATIONAL OBJECTIVES:
Upon completion of this program, participants will be able to:
  1. Recognize physiological changes that occur during peri-menopause.
  2. Identify pathology that may occur during peri-menopause.
  3. Improve their understanding of clinical tests commonly administered during the menopausal transition.
  4. Develop a primary understanding of pharmacological and non-pharmacological therapies commonly used during the climacteric.
  5. Develop a greater understanding of the controversy regarding hormone replacement therapy for prevention purposes.
CE Course Outline

Step 1: Print slides/handouts (pdf)
Step 2: View Presentation (flash video)
Step 3: Take CE Exam
Step 4: Quick Evaluation
Step 5: Print CE Certificate


Tell A Friend...
about this continuing education opportunity! Simply enter the email address of up to 3 colleagues, friends or family members and we will email them information about this program.

Email Addresses:
My Name:
My Email:

AUDIENCE:
The audience for this program is nurses and nurse practitioners specializing in cardiovascular risk reduction and disease management.

FACULTY DISCLOSURES:
Speakers Bureau: American Association of Diabetes Educators, Am Pharmacists, Lilly, Aventis, Novo Nordisk, Advisory Board/Consultant: Abbott/Therasense, Lilly, GSK.

SPONSOR/ACCREDITOR:
This activity is sponsored by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners (AANP) - provider number 030602. PCNA will provide 1 contact hour of continuing education for this program.

GRANTOR:
This CE activity is supported by an unrestricted educational grant from Pfizer, Inc. as part of Pfizer's support of the Amelia Island Consortium for Healthcare Practitioner Education (AIC).

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the slides and accompanying notes; complete the online exam and evaluation form at the end of the activity; and submit your results electronically. There is no registration fee. Exams will be graded and results displayed instantaneously. Participants who receive a passing score of 70% or higher will receive an electronic, printable certificate of credit immediately after completing the exam. You will have 2 opportunities to successfully complete the exam.

DISCLAIMER:
Persons who are taking this online course are urged to remember that scientific knowledge is advancing and changing at an exponential rate. Thus, it is possible that the content of this presentation may quickly become dated. The astute evidence-based practitioner is urged to seek out the most current information following completion of this course.

Click here to take this CE